サマリー

市場の分析と洞察。甲状腺ホルモン障害治療薬の世界市場
COVID-19の流行により、甲状腺ホルモン障害薬の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に甲状腺ホルモン障害薬世界市場の％を占めた注射甲状腺ホルモン障害薬は、2028年までに百万米ドルの価値を持ち、ポストCOVID-19期間に改訂された％のCAGRで成長すると予測されています。一方、病院セグメントは、この予測期間を通じて、CAGRに変更されています。
中国の甲状腺ホルモン障害治療薬の市場規模は2021年に百万米ドル、米国と欧州の甲状腺ホルモン障害治療薬はそれぞれ百万米ドル、百万米ドルと評価されています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の甲状腺ホルモン障害治療薬の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
甲状腺ホルモン剤の世界的な主要メーカーは、Novo Nordisk、Sanofi、Merck、Eli Lilly、AstraZeneca、AbbVieなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。
世界の甲状腺ホルモン障害治療薬の範囲とセグメント
甲状腺ホルモン障害治療薬市場は、タイプ別と用途別に分類されます。世界の甲状腺ホルモン障害治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
注射用甲状腺ホルモン剤
経口甲状腺ホルモン剤
その他
用途別セグメント
病院
クリニック
医療機関
その他
会社別
ノボ ノルディスク
サノフィ
メルク
イーライ・リリー
アストラゼネカ
アッヴィー
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Thyroid Hormone Disorder Drug Product Introduction
1.2 Market by Type
1.2.1 Global Thyroid Hormone Disorder Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection Thyroid Hormone Disorder Drug
1.2.3 Oral Thyroid Hormone Disorder Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Thyroid Hormone Disorder Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Thyroid Hormone Disorder Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Thyroid Hormone Disorder Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Thyroid Hormone Disorder Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Thyroid Hormone Disorder Drug Sales by Region
2.4.1 Global Thyroid Hormone Disorder Drug Sales by Region (2017-2022)
2.4.2 Global Sales Thyroid Hormone Disorder Drug by Region (2023-2028)
2.5 Global Thyroid Hormone Disorder Drug Revenue by Region
2.5.1 Global Thyroid Hormone Disorder Drug Revenue by Region (2017-2022)
2.5.2 Global Thyroid Hormone Disorder Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Thyroid Hormone Disorder Drug Sales by Manufacturers
3.1.1 Global Top Thyroid Hormone Disorder Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Thyroid Hormone Disorder Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thyroid Hormone Disorder Drug in 2021
3.2 Global Thyroid Hormone Disorder Drug Revenue by Manufacturers
3.2.1 Global Thyroid Hormone Disorder Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Thyroid Hormone Disorder Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Thyroid Hormone Disorder Drug Revenue in 2021
3.3 Global Thyroid Hormone Disorder Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Thyroid Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Thyroid Hormone Disorder Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Thyroid Hormone Disorder Drug Sales by Type
4.1.1 Global Thyroid Hormone Disorder Drug Historical Sales by Type (2017-2022)
4.1.2 Global Thyroid Hormone Disorder Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Thyroid Hormone Disorder Drug Sales Market Share by Type (2017-2028)
4.2 Global Thyroid Hormone Disorder Drug Revenue by Type
4.2.1 Global Thyroid Hormone Disorder Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Thyroid Hormone Disorder Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Thyroid Hormone Disorder Drug Revenue Market Share by Type (2017-2028)
4.3 Global Thyroid Hormone Disorder Drug Price by Type
4.3.1 Global Thyroid Hormone Disorder Drug Price by Type (2017-2022)
4.3.2 Global Thyroid Hormone Disorder Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Thyroid Hormone Disorder Drug Sales by Application
5.1.1 Global Thyroid Hormone Disorder Drug Historical Sales by Application (2017-2022)
5.1.2 Global Thyroid Hormone Disorder Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Thyroid Hormone Disorder Drug Sales Market Share by Application (2017-2028)
5.2 Global Thyroid Hormone Disorder Drug Revenue by Application
5.2.1 Global Thyroid Hormone Disorder Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Thyroid Hormone Disorder Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Thyroid Hormone Disorder Drug Revenue Market Share by Application (2017-2028)
5.3 Global Thyroid Hormone Disorder Drug Price by Application
5.3.1 Global Thyroid Hormone Disorder Drug Price by Application (2017-2022)
5.3.2 Global Thyroid Hormone Disorder Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Thyroid Hormone Disorder Drug Market Size by Type
6.1.1 North America Thyroid Hormone Disorder Drug Sales by Type (2017-2028)
6.1.2 North America Thyroid Hormone Disorder Drug Revenue by Type (2017-2028)
6.2 North America Thyroid Hormone Disorder Drug Market Size by Application
6.2.1 North America Thyroid Hormone Disorder Drug Sales by Application (2017-2028)
6.2.2 North America Thyroid Hormone Disorder Drug Revenue by Application (2017-2028)
6.3 North America Thyroid Hormone Disorder Drug Market Size by Country
6.3.1 North America Thyroid Hormone Disorder Drug Sales by Country (2017-2028)
6.3.2 North America Thyroid Hormone Disorder Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Thyroid Hormone Disorder Drug Market Size by Type
7.1.1 Europe Thyroid Hormone Disorder Drug Sales by Type (2017-2028)
7.1.2 Europe Thyroid Hormone Disorder Drug Revenue by Type (2017-2028)
7.2 Europe Thyroid Hormone Disorder Drug Market Size by Application
7.2.1 Europe Thyroid Hormone Disorder Drug Sales by Application (2017-2028)
7.2.2 Europe Thyroid Hormone Disorder Drug Revenue by Application (2017-2028)
7.3 Europe Thyroid Hormone Disorder Drug Market Size by Country
7.3.1 Europe Thyroid Hormone Disorder Drug Sales by Country (2017-2028)
7.3.2 Europe Thyroid Hormone Disorder Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Thyroid Hormone Disorder Drug Market Size by Type
8.1.1 Asia Pacific Thyroid Hormone Disorder Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Thyroid Hormone Disorder Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Thyroid Hormone Disorder Drug Market Size by Application
8.2.1 Asia Pacific Thyroid Hormone Disorder Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Thyroid Hormone Disorder Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Thyroid Hormone Disorder Drug Market Size by Region
8.3.1 Asia Pacific Thyroid Hormone Disorder Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Thyroid Hormone Disorder Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Thyroid Hormone Disorder Drug Market Size by Type
9.1.1 Latin America Thyroid Hormone Disorder Drug Sales by Type (2017-2028)
9.1.2 Latin America Thyroid Hormone Disorder Drug Revenue by Type (2017-2028)
9.2 Latin America Thyroid Hormone Disorder Drug Market Size by Application
9.2.1 Latin America Thyroid Hormone Disorder Drug Sales by Application (2017-2028)
9.2.2 Latin America Thyroid Hormone Disorder Drug Revenue by Application (2017-2028)
9.3 Latin America Thyroid Hormone Disorder Drug Market Size by Country
9.3.1 Latin America Thyroid Hormone Disorder Drug Sales by Country (2017-2028)
9.3.2 Latin America Thyroid Hormone Disorder Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Thyroid Hormone Disorder Drug Market Size by Type
10.1.1 Middle East and Africa Thyroid Hormone Disorder Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Thyroid Hormone Disorder Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Thyroid Hormone Disorder Drug Market Size by Application
10.2.1 Middle East and Africa Thyroid Hormone Disorder Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Thyroid Hormone Disorder Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Thyroid Hormone Disorder Drug Market Size by Country
10.3.1 Middle East and Africa Thyroid Hormone Disorder Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Thyroid Hormone Disorder Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Overview
11.6.3 AbbVie Thyroid Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie Thyroid Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Thyroid Hormone Disorder Drug Industry Chain Analysis
12.2 Thyroid Hormone Disorder Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Thyroid Hormone Disorder Drug Production Mode & Process
12.4 Thyroid Hormone Disorder Drug Sales and Marketing
12.4.1 Thyroid Hormone Disorder Drug Sales Channels
12.4.2 Thyroid Hormone Disorder Drug Distributors
12.5 Thyroid Hormone Disorder Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Thyroid Hormone Disorder Drug Industry Trends
13.2 Thyroid Hormone Disorder Drug Market Drivers
13.3 Thyroid Hormone Disorder Drug Market Challenges
13.4 Thyroid Hormone Disorder Drug Market Restraints
14 Key Findings in The Global Thyroid Hormone Disorder Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer